Target intelligence / Profile preview

P2X purinoceptor 7 mRNA 3' untranslated region (P2X7 mRNA 3'UTR)

Target
P2X7 mRNA 3'UTR
Molecular classification
RNA, Untranslated region, Regulatory RNA element
01

Overview

The P2X purinoceptor 7 (P2X7) mRNA 3' untranslated region (3'UTR) is a critical regulatory segment of the P2RX7 gene transcript that controls the post-transcriptional expression of the P2X7 receptor protein (Zhou et al., 2008, PMID: 18660825). The P2X7 receptor is a trimeric ligand-gated ion channel activated by high concentrations of extracellular ATP, serving as a key driver of the NLRP3 inflammasome and the release of pro-inflammatory cytokines like IL-1β (Di Virgilio et al., 2017, PMID: 28610988). The 3'UTR contains binding sites for various microRNAs, most notably miR-150, which act as physiological brakes by promoting mRNA degradation or inhibiting translation to prevent receptor over-expression (Gu et al., 2015, PMID: 25614451). Dysregulation of these interactions, often through the downregulation of regulatory microRNAs, is associated with chronic inflammatory conditions, neuropathic pain, and neurodegenerative diseases such as Alzheimer's (De Marchi et al., 2016, PMID: 27156353). Therapeutic strategies targeting the P2X7 mRNA 3'UTR, including microRNA mimics and antisense oligonucleotides, aim to normalize P2X7 protein levels rather than simply blocking the channel's pore. This approach offers a nuanced method for modulating purinergic signaling and may provide more sustained anti-inflammatory effects compared to traditional small-molecule antagonists.

Other names
P2RX7 3'UTRPurinergic receptor P2X 7 mRNA 3' untranslated regionP2X7 receptor mRNA 3'UTRP2X7R 3'UTR
02

Mechanism of action

Modulation of P2X7 protein expression levels through microRNA-mediated mRNA degradation or translational inhibition by targeting specific regulatory sequences within the 3' untranslated region.

03

Biological functions

Post-transcriptional gene regulationmRNA stability regulationTranslational repressionmRNA localization
04

Disease associations

InflammationNeurodegenerative diseaseNeuropathic painAutoimmune diseaseCancer
05

Safety considerations

Off-target hybridization to other mRNA transcriptsInnate immune activation by exogenous RNA moleculesDelivery challenges to specific tissues (e.g., CNS)Potential for unintended silencing of other purinergic receptor subtypes
06

Interacting drugs

miR-150 mimics

3 more in the full profile.

07

Biomarkers

P2X7 protein expression levelsCirculating miR-150 levelsInterleukin-1 beta (IL-1β) levelsC-reactive protein (CRP)

Beyond the preview

Go deeper on P2X purinoceptor 7 mRNA 3' untranslated region (P2X7 mRNA 3'UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on P2X purinoceptor 7 mRNA 3' untranslated region (P2X7 mRNA 3'UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call